{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:54:13Z","timestamp":1790679253353,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ebiom.2020.102633","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T19:12:45Z","timestamp":1579720365000},"page":"102633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Enhanced thrombospondin-1 causes dysfunction of vascular endothelial cells derived from Fabry disease-induced pluripotent stem cells"],"prefix":"10.1016","volume":"52","author":[{"given":"Hyo-Sang","family":"Do","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkyun","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghyuk","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Wook","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heounjeong","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gou Young","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Mahn","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.102633_bib0001","series-title":"The online metabolic and molecular bases of inherited disease","article-title":"\u03b1-Galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2014"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102633_bib0002","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-146-6-200703200-00007","article-title":"Narrative review: Fabry disease","volume":"146","author":"Clarke","year":"2007","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102633_bib0003","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102633_bib0004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102633_bib0005","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","article-title":"High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population","volume":"2","author":"Lin","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102633_bib0006","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.2007.08002.x","article-title":"Fabry disease and the skin: data from FOS, the Fabry outcome survey","volume":"157","author":"Orteu","year":"2007","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102633_bib0007","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","article-title":"Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy","volume":"24","author":"Schiffmann","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102633_bib0008","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.ebiom.2020.102633_bib0009","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/080352502762457888","article-title":"Pathophysiology and assessment of neuropathic pain in Fabry disease","volume":"91","author":"Cleeland","year":"2002","journal-title":"Acta Paediatr"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102633_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.ebiom.2020.102633_bib0011","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2020.102633_bib0012","first-page":"9","article-title":"Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain","volume":"8","author":"Rombach","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102633_bib0013","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MD.0000000000006063","article-title":"Life-threatening bleeding from gastric mucosal angiokeratomas during anticoagulation A case report of Fabry disease","volume":"96","author":"Kang","year":"2017","journal-title":"Medicine"},{"issue":"29","key":"10.1016\/j.ebiom.2020.102633_bib0014","doi-asserted-by":"crossref","first-page":"20960","DOI":"10.1074\/jbc.M702436200","article-title":"Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null mice","volume":"282","author":"Shu","year":"2007","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102633_bib0015","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3892\/ijmm.2012.1139","article-title":"Possible role of transforming growth factor-\u03b21 and vascular endothelial growth factor in Fabry disease nephropathy","volume":"30","author":"Lee","year":"2012","journal-title":"Int J Mol Med"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102633_bib0016","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/cvr\/cvq333","article-title":"Globotriaosylceramide leads to K(Ca)3.1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease","volume":"89","author":"Park","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ebiom.2020.102633_bib0017","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BJ20130825","article-title":"A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis","volume":"456","author":"Taguchi","year":"2013","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102633_bib0018","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ymgme.2013.06.003","article-title":"Morphological features of iPS cells generated from Fabry disease skin fibroblasts using Sendai virus vector (SeVdp)","volume":"109","author":"Kawagoe","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102633_bib0019","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10545-014-9724-5","article-title":"Effective clearance of GL-3 in a human iPSC-derived cardiomyocyte model of Fabry disease","volume":"37","author":"Itier","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ebiom.2020.102633_bib0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijcard.2017.01.009","article-title":"Energy utilization of induced pluripotent stem cell-derived cardiomyocyte in Fabry disease","volume":"232","author":"Chou","year":"2017","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102633_bib0021","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1242\/jcs.107.1.39","article-title":"Comparison of normal and tumorigenic endothelial cells: differences in thrombospondin production and responses to transforming growth factor-beta","volume":"107","author":"RayChaudhury","year":"1994","journal-title":"J Cell Sci"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102633_bib0022","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.biocel.2004.01.025","article-title":"Thrombospondin modules and angiogenesis","volume":"36","author":"Iruela-Arispe","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102633_bib0023","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.ebiom.2020.102633_bib0024","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1182\/blood-2010-04-280719","article-title":"Efficient differentiation of human pluripotent stem cells into functional CD34(+) progenitor cells by combined modulation of the MEK\/ERK and BMP4 signaling pathways","volume":"116","author":"Park","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2020.102633_bib0025","series-title":"ImageJ contribution: angiogenesis analyzer","author":"Carpentier","year":"2012"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102633_bib0026","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10545-009-1077-0","article-title":"The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell lines","volume":"32","author":"Benjamin","year":"2009","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102633_bib0027","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102633_bib0028","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10719-007-9091-7","article-title":"Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer\/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity","volume":"25","author":"Schweppe","year":"2008","journal-title":"Glycoconj J"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102633_bib0029","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","article-title":"Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases","volume":"30","author":"Bae","year":"2014","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102633_bib0030","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/bioinformatics\/btw561","article-title":"Cas-analyzer: an online tool for assessing genome editing results using NGS data","volume":"33","author":"Park","year":"2017","journal-title":"Bioinformatics"},{"issue":"1-2","key":"10.1016\/j.ebiom.2020.102633_bib0031","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ymgme.2007.06.003","article-title":"Establishment and characterization of Fabry disease endothelial cells with an extended lifespan","volume":"92","author":"Shen","year":"2007","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102633_bib0032","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1009018702832","article-title":"Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis","volume":"3","author":"Gupta","year":"1999","journal-title":"Angiogenesis"},{"issue":"13","key":"10.1016\/j.ebiom.2020.102633_bib0033","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1182\/blood-2003-03-0893","article-title":"Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2","volume":"102","author":"Margosio","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102633_bib0034","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/ph3041241","article-title":"Thrombospondin-1 as a paradigm for the development of antiangiogenic agents endowed with multiple mechanisms of action","volume":"3","author":"Rusnati","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102633_bib0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jcp.10059","article-title":"Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide","volume":"190","author":"Wang","year":"2002","journal-title":"J Cell Physiol"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102633_bib0036","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.placenta.2008.05.005","article-title":"Differential activation of multiple signalling pathways dictates eNOS upregulation by FGF2 but not VEGF in placental artery endothelial cells","volume":"29","author":"Mata-Greenwood","year":"2008","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102633_bib0037","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1523-1755.2004.00395.x","article-title":"Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo","volume":"65","author":"Daniel","year":"2004","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102633_bib0038","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01606034","article-title":"Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease","volume":"417","author":"Elleder","year":"1990","journal-title":"Virchows Arch A"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102633_bib0039","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","article-title":"A phase 1\/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies","volume":"68","author":"Eng","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102633_bib0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/bdrc.10024","article-title":"From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis","volume":"69","author":"Harry","year":"2003","journal-title":"Birth Defects Res Part C Embryo Today Rev"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102633_bib0041","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrc2353","article-title":"Integrins in angiogenesis and lymphangiogenesis","volume":"8","author":"Avraamides","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102633_bib0042","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1101\/gad.13.9.1055","article-title":"Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development","volume":"13","author":"Gale","year":"1999","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102633_bib0043","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-6147(00)01676-X","article-title":"FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition","volume":"22","author":"Cross","year":"2001","journal-title":"Trends Pharmacol Sci"},{"issue":"6626","key":"10.1016\/j.ebiom.2020.102633_bib0044","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","article-title":"Mechanisms of angiogenesis","volume":"386","author":"Risau","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102633_bib0045","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1073\/pnas.97.6.2626","article-title":"Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis","volume":"97","author":"Oh","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"10.1016\/j.ebiom.2020.102633_bib0046","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1074\/jbc.271.19.11500","article-title":"Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2\/flk-1 expression in vascular endothelial cells","volume":"271","author":"Mandriota","year":"1996","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102633_bib0047","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/ph3041241","article-title":"Thrombospondin-1 as a paradigm for the development of antiangiogenic agents endowed with multiple mechanisms of action","volume":"3","author":"Rusnati","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102633_bib0048","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/10409238.2015.1014024","article-title":"CD47 signaling pathways controlling cellular differentiation and responses to stress","volume":"50","author":"Soto-Pantoja","year":"2015","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102633_bib0049","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/ATVBAHA.110.220624","article-title":"Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties","volume":"31","author":"Smadja","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102633_bib0050","first-page":"923","article-title":"Thrombospondin causes activation of latent transforming growth-factor-beta secreted by endothelial-cells by a novel mechanism","volume":"122","author":"Schultzcherry","year":"1993","journal-title":"J Cell Biol"},{"issue":"1-2","key":"10.1016\/j.ebiom.2020.102633_bib0051","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1359-6101(99)00029-5","article-title":"Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology","volume":"11","author":"Murphy-Ullrich","year":"2000","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102633_bib0052","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1523-1755.2004.00780.x","article-title":"TGF-\u03b2 induces proangiogenic and antiangiogenic factorsvia parallel but distinct Smad pathways1","volume":"66","author":"Nakagawa","year":"2004","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102633_bib0053","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1371\/journal.pone.0204618","article-title":"Oxidative stress and the altered reaction to it in Fabry disease: a possible target for cardiovascular-renal remodeling?","volume":"13","author":"Ravarotto","year":"2018","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.ebiom.2020.102633_bib0054","doi-asserted-by":"crossref","first-page":"19012","DOI":"10.1074\/jbc.M413344200","article-title":"Novel role for amphiregulin in protection from liver injury","volume":"280","author":"Berasain","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2020.102633_bib0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.freeradbiomed.2015.03.024","article-title":"COX-2 is involved in vascular oxidative stress and endothelial dysfunction of renal interlobar arteries from obese Zucker rats","volume":"84","author":"Munoz","year":"2015","journal-title":"Free Radic Biol Med"},{"issue":"28","key":"10.1016\/j.ebiom.2020.102633_bib0056","doi-asserted-by":"crossref","first-page":"21590","DOI":"10.1074\/jbc.M109.070169","article-title":"Peroxisome proliferator-activated receptor gamma co-activator 1 alpha (PGC-1 alpha) and sirtuin 1 (SIRT1) reside in mitochondria possible direct function in mitochondrial biogenesis","volume":"285","author":"Aquilano","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2020.102633_bib0057","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/cddis.2014.458","article-title":"PGC-1 alpha buffers ROS-mediated removal of mitochondria during myogenesis","volume":"5","author":"Baldelli","year":"2014","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102633_bib0058","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cmet.2013.12.014","article-title":"Endothelial PGC-1 alpha mediates vascular dysfunction in diabetes","volume":"19","author":"Sawada","year":"2014","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102633_bib0059","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1161\/ATVBAHA.115.306541","article-title":"DLL4\/Notch1 and BMP9 interdependent signaling induces human endothelial cell quiescence via P27(KIP1) and thrombospondin-1","volume":"35","author":"Rostama","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ebiom.2020.102633_bib0060","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1074\/jbc.M706974200","article-title":"Neuralized-like 1 (Neurl1) targeted to the plasma membrane by N-myristoylation regulates the notch ligand jagged1","volume":"283","author":"Koutelou","year":"2008","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102633_bib0061","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/hep.24800","article-title":"Thrombospondin-1 is a novel negative regulator of liver regeneration after partial hepatectomy through transforming growth factor-beta1 activation in mice","volume":"55","author":"Hayashi","year":"2012","journal-title":"Hepatology"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420300086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420300086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:56:49Z","timestamp":1762455409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420300086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":61,"alternative-id":["S2352396420300086"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102633","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced thrombospondin-1 causes dysfunction of vascular endothelial cells derived from Fabry disease-induced pluripotent stem cells","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102633"}}